Nuvation Bio Inc.
NUVB
$2.18
$0.020.93%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.71M | 727.00K | 1.44M | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.71M | 727.00K | 1.44M | -- | -- |
| Cost of Revenue | 4.22M | 1.52M | 1.35M | -- | -- |
| Gross Profit | 1.50M | -788.00K | 88.00K | -- | -- |
| SG&A Expenses | 26.14M | 19.58M | 16.16M | 7.36M | 5.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 59.65M | 48.83M | 471.82M | 20.20M | 20.83M |
| Operating Income | -53.94M | -48.10M | -470.39M | -20.20M | -20.83M |
| Income Before Tax | -49.45M | -41.21M | -462.49M | -14.79M | -13.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -49.45M | -41.21M | -462.49M | -14.79M | -13.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.45M | -41.21M | -462.49M | -14.79M | -13.79M |
| EBIT | -53.94M | -48.10M | -470.39M | -20.20M | -20.83M |
| EBITDA | -53.72M | -47.94M | -470.14M | -20.14M | -20.78M |
| EPS Basic | -0.15 | -0.15 | -1.89 | -0.07 | -0.06 |
| Normalized Basic EPS | -0.09 | -0.09 | -1.18 | -0.04 | -0.04 |
| EPS Diluted | -0.15 | -0.15 | -1.89 | -0.07 | -0.06 |
| Normalized Diluted EPS | -0.09 | -0.09 | -1.18 | -0.04 | -0.04 |
| Average Basic Shares Outstanding | 336.93M | 273.57M | 244.74M | 219.05M | 218.99M |
| Average Diluted Shares Outstanding | 336.93M | 273.57M | 244.74M | 219.05M | 218.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |